**Appendices and nomenclature**



#### **Table A1.**

*Summary of nanoparticles ferrite type (FT) obtained by different methods with their sizes (S), morphology (Mo), saturation magnetization (MS), coercivity (HC) and remanence (MR), reported in the literature (R). The magnetic properties were reported at room temperature.*


*Nanoferrites-Based Drug Delivery Systems as Adjuvant Therapy for Cancer Treatments.… DOI: http://dx.doi.org/10.5772/intechopen.100225*

#### **Table A2.**

*Summary of nanoparticles ferrite type (FT) loaded (Fe: Magnetite) with different anticancer drugs (D: Docetaxel, T: Tamoxifen, C: Curcumin; do: Doxorubicin, M: Methotrexate, I: Imatinib, H: Hesperidin, Z: Zidovudine, zo:Zoledronic acid, 5-F: 5-fluorouracil, ci: Cinnamaldehyde, Cis: Cisplatin, and E: Epirubicin,), the solvent (sol) used for loading (D: Dichloromethane, E: Ethanol, W: Water, and S: Saline solution) and the quantity (QS, in mL), the loading capacity (LD), the temperature (T), time (t, in hours), and percentage (% L) of loading, with their references (R).*

## *Ferrites - Synthesis and Applications*


#### **Table A3.**

*Summary of drug delivery conditions and results, reported in the literature for ferrite nanoparticles loaded with anticancer drugs (system). The main conditions are the pH, the time (t) and the temperature (T) of release. The drug release (DR) percentage measure the efficiency of the process.*

*Nanoferrites-Based Drug Delivery Systems as Adjuvant Therapy for Cancer Treatments.… DOI: http://dx.doi.org/10.5772/intechopen.100225*
